CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Use of Symbios Bone Graft Material +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04331314
NCT04331314N/ACompleted
CompareCT.gov

Sinus Augmentation Using Symbios Versus Algipore as Bone Graft Material - A Randomized Controlled Clinical Pilot Study

Medical University of Graz·interventional·Posted Apr 2, 2020·Updated Apr 2, 2020

In Brief

A clinical study evaluating Use of Symbios Bone Graft Material and Algipore Bone Substitution Material for Bone Substitutes and 4 related conditions. Completed, enrolled 20 participants.

Detailed Summary

Twenty patients scheduled for lateral-window sinus floor Elevation (SFE) are randomized into two groups: use of SYMBIOS® Biphasic Bone Graft Material (Group 1) or of Algipore® Bone Substitution Material (Group 2). Biopsies are taken 3 months after SFE and during implant surgery after 6 months. One ground section per biopsy (n=40) is stained, scanned, and histomorphometrically analyzed for new bone, old bone, soft tissue, graft, bone infiltration of graft, bone-to-graft contact, and penetration depth.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Substitutes, Calcium Phosphates, Hydroxyapatite, Rhodophyta, Sinus Floor Augmentation
Countries--
CollaboratorsDentsply Sirona Implants and Consumables

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2, 2020
Enrollment StartFeb 23, 2015
Primary CompletionMar 20, 2018
Study CompletionOct 28, 2019
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.3 years ago

Interventions

Use of Symbios Bone Graft Materialdevice

Patients will receive Symbios Bone Graft Material according to randomization Group.

Algipore Bone Substitution Materialdevice

Patients will receive Algipore Bone Substitution Material according to randomization Group.